Patient Awareness of CAR-T and Bispecific Antibody Treatments for Multiple Myeloma: Real-World Learnings and Disparities

被引：0
|
作者：
Adu, Yaw [1 ]
Das, Saurav [2 ]
Ailawadhi, Dhaani [3 ]
Fernandez, Andre [2 ]
Parrondo, Ricardo [2 ]
Roy, Vivek [2 ]
Sher, Taimur [2 ]
O'Connell, Sean [4 ]
Rasheed, Ahsan [2 ]
Chanan-Khan, Asher A. [2 ]
Ailawadhi, Sikander [2 ]
机构：
[1] Texas Tech Univ, Hlth Sci Ctr, Sch Med, Lubbock, TX USA
[2] Mayo Clin, Div Hematol Oncol, Jacksonville, FL USA
[3] Bolles Middle Sch, Jacksonville, FL USA
[4] Mayo Clin, Sch Continuous Profess Dev, Jacksonville, FL USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-189642
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Bispecific BCMA/CD24 CAR-T cells control multiple myeloma growth
    Fumou Sun
    Yan Cheng
    Visanu Wanchai
    Wancheng Guo
    David Mery
    Hongwei Xu
    Dongzheng Gai
    Eric Siegel
    Clyde Bailey
    Cody Ashby
    Samer Al Hadidi
    Carolina Schinke
    Sharmilan Thanendrarajan
    Yupo Ma
    Qing Yi
    Robert Z. Orlowski
    Maurizio Zangari
    Frits van Rhee
    Siegfried Janz
    Gail Bishop
    Guido Tricot
    John D. Shaughnessy
    Fenghuang Zhan
    Nature Communications, 15
  • [22] Idecabtagene Vicleucel for Relapsed/Refractory Multiple Myeloma: Real-World Experience From the Myeloma CAR T Consortium
    Hansen, Doris K.
    Sidana, Surbhi
    Peres, Lauren C.
    Leitzinger, Christelle Colin
    Shune, Leyla
    Shrewsbury, Alexandria
    Gonzalez, Rebecca
    Sborov, Douglas W.
    Wagner, Charlotte
    Dima, Danai
    Hashmi, Hamza
    Kocoglu, Mehmet H.
    Atrash, Shebli
    Simmons, Gary
    Kalariya, Nilesh
    Ferreri, Christopher
    Afrough, Aimaz
    Kansagra, Ankit
    Voorhees, Peter
    Baz, Rachid
    Khouri, Jack
    Alsina, Melissa
    McGuirk, Joseph
    Locke, Frederick L.
    Patel, Krina K.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (11) : 2087 - +
  • [23] Novel CS1 CAR-T Cells and Bispecific CS1-BCMA CAR-T Cells Effectively Target Multiple Myeloma
    Golubovskaya, Vita
    Zhou, Hua
    Li, Feng
    Berahovich, Robert
    Sun, Jinying
    Valentine, Michael
    Xu, Shirley
    Harto, Hizkia
    Sienkiewicz, John
    Huang, Yanwei
    Wu, Lijun
    BIOMEDICINES, 2021, 9 (10)
  • [24] Real-world barriers to CAR-T access: A Canadian referral center perspective
    Shi, Steven
    Laverdure, Eva
    Cohen, Sandra R. A.
    Veilleux, Olivier
    Lachance, Silvy
    Mollica, Luigina
    Fleury, Isabelle
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [25] Multiple immunoglobulin isotype switch after bispecific CAR-T cell therapy in multiple myeloma-A case report
    Li, Chenggong
    Liu, Jiachen
    Deng, Jun
    Xu, Jia
    Kang, Yun
    Luo, Wenjing
    Chen, Lei
    Hu, Yu
    Mei, Heng
    BRITISH JOURNAL OF HAEMATOLOGY, 2023, 200 (04) : 528 - 531
  • [26] Patient Preferences for use of CAR-T therapy as an Early Line Treatment in Multiple Myeloma
    Hansen, Doris
    Khouri, Jack
    Puglianini, Omar Castaneda
    De Braganca, Kevin
    De Wiest, Denise
    Perciavalle, Matthew
    Lengil, Tamar
    Huo, Stephen
    Lee, Seina
    Krupsky, Kathryn
    Cohn, Jesse
    Brighton, Elizabeth
    Bixby, Todd
    Qureshi, Zaina
    Richard, Shambavi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S112 - S113
  • [27] Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma
    Chenggong Li
    Jia Xu
    Wenjing Luo
    Danying Liao
    Wei Xie
    Qiuzhe Wei
    Yinqiang Zhang
    Xindi Wang
    Zhuolin Wu
    Yun Kang
    Jin’e Zheng
    Wei Xiong
    Jun Deng
    Yu Hu
    Heng Mei
    Leukemia, 2024, 38 : 149 - 159
  • [28] Bispecific CS1-BCMA CAR-T cells are clinically active in relapsed or refractory multiple myeloma
    Li, Chenggong
    Xu, Jia
    Luo, Wenjing
    Liao, Danying
    Xie, Wei
    Wei, Qiuzhe
    Zhang, Yinqiang
    Wang, Xindi
    Wu, Zhuolin
    Kang, Yun
    Zheng, Jin'e
    Xiong, Wei
    Deng, Jun
    Hu, Yu
    Mei, Heng
    LEUKEMIA, 2024, 38 (01) : 149 - 159
  • [29] High efficacy and safety of CD38 and BCMA bispecific CAR-T in relapsed or refractory multiple myeloma
    Yuanyan Tang
    Haisen Yin
    Xinying Zhao
    Dan Jin
    Yan Liang
    Tao Xiong
    Lu Li
    Wen Tang
    Jiangzhao Zhang
    Min Liu
    Zhuojun Yu
    Huimin Liu
    Sibin Zang
    Zhiping Huang
    Journal of Experimental & Clinical Cancer Research, 41
  • [30] The Investigation of Antitumor Effect of Humanized Bispecific BCMA/CD38 CAR-T Cells on Multiple Myeloma
    Chen, Zhaoqi
    Lu, Yang
    Xu, Yingxi
    Qiu, Shaowei
    Gu, Runxia
    Xing, Haiyan
    Tang, Kejing
    Tian, Zheng
    Rao, Qing
    Xiong, Dongsheng
    Wang, Min
    Wang, Jianxiang
    BLOOD, 2022, 140 : 7402 - 7403
12345